These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 10546125

  • 1. [Guidelines and clinical practice: anticoagulant therapy and cardioversion in atrial fibrillation].
    Callegari S, Pini M, Andreoli L.
    G Ital Cardiol; 1999 Oct; 29(10):1157-63. PubMed ID: 10546125
    [Abstract] [Full Text] [Related]

  • 2. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
    Antonielli E, Pizzuti A, Gandolfo N, Sclavo M, Tanga M, Riva G, Leonardi G, Bassignana A, Di Leo M.
    G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
    [Abstract] [Full Text] [Related]

  • 3. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation.
    Schlicht JR, Davis RC, Naqi K, Cooper W, Rao BV.
    Arch Intern Med; 1996 Feb 12; 156(3):290-4. PubMed ID: 8572839
    [Abstract] [Full Text] [Related]

  • 4. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A, Eskilsson J, Olsson B.
    Eur Heart J; 2000 May 12; 21(10):837-47. PubMed ID: 10781356
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P, Geller C, Mügge A, Sehnert W, Schmidt-Lucke C, Schmidt-Lucke JA, ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group.
    Circulation; 2004 Mar 02; 109(8):997-1003. PubMed ID: 14967716
    [Abstract] [Full Text] [Related]

  • 6. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.
    Can J Cardiol; 2005 Mar 02; 21(3):257-66. PubMed ID: 15776115
    [Abstract] [Full Text] [Related]

  • 7. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi.
    Manning WJ, Silverman DI, Gordon SP, Krumholz HM, Douglas PS.
    N Engl J Med; 1993 Mar 18; 328(11):750-5. PubMed ID: 8437595
    [Abstract] [Full Text] [Related]

  • 8. [Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future].
    Schimpf T, Stellbrink C.
    Med Klin (Munich); 2003 Feb 15; 98(2):91-5. PubMed ID: 12601533
    [Abstract] [Full Text] [Related]

  • 9. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
    Thibault B, Talajic M, Dubuc M, Guerra P, Gagné P, Roy D, Connolly S, Canadian Trial of Atrial Fibrillation.
    Can J Cardiol; 2004 Feb 15; 20(2):195-9. PubMed ID: 15010743
    [Abstract] [Full Text] [Related]

  • 10. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 15; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 11. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF.
    Eur Heart J; 2000 Jan 15; 21(1):66-73. PubMed ID: 10610746
    [Abstract] [Full Text] [Related]

  • 12. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG, Albers GW.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):929-35. PubMed ID: 15028346
    [Abstract] [Full Text] [Related]

  • 13. Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.
    Elliott DJ, Zhao L, Jasper SE, Lieber EA, Klein AL, Weintraub WS.
    Am Heart J; 2008 Aug 17; 156(2):374.e1-6. PubMed ID: 18657673
    [Abstract] [Full Text] [Related]

  • 14. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL, Dublin S, Smith NL, French B, Jackson LA, Hrachovec JB, Siscovick DS, Psaty BM, Heckbert SR.
    Arch Intern Med; 2007 Feb 12; 167(3):246-52. PubMed ID: 17296879
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A.
    Orv Hetil; 2004 May 09; 145(19):1001-6. PubMed ID: 15181735
    [Abstract] [Full Text] [Related]

  • 16. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL, Abid S, Teo K, Oczkowski W, O'Donnell MJ.
    Thromb Res; 2007 May 09; 120(5):663-9. PubMed ID: 17434577
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anticoagulation for cardioversion of atrial fibrillation.
    El Gendi H, Ismail T, Charalampos K, Mayet J.
    Minerva Cardioangiol; 2002 Feb 09; 50(1):43-52. PubMed ID: 11830718
    [Abstract] [Full Text] [Related]

  • 19. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL, Corbett TL.
    Ann Pharmacother; 2008 Apr 09; 42(4):523-32. PubMed ID: 18334606
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.